Global Umbilical Cord Blood Stem Cell Market Is Expected to Reach $56.4 Billion by 2020 - Allied Market Research

According to the report published by Allied Market Research, the global market for Umbilical Cord Blood Stem Cell is expected to reach revenue of $56.4 billion by 2020, growing at CAGR of 33.4% during 2013 to 2020.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend
Cord blood stem cell application is increasing at faster rate than other stem cell techniques because of its efficient and cost effective treatment process. Cord blood is assisting thehealthcare industry to discover novel therapies on chronic diseases.

Portland, Oregon (PRWEB UK) 9 June 2014

Allied Market Research today announced the most comprehensive and strategically analyzed report titled "Stem Cell Umbilical Cord Blood (UCB) Market (Storage Services, Therapeutics, Applications and Geography) - Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast, 2012 - 2020". The study observed that the global umbilical cord blood stem cell market is forecasted to reach market value over $11.5 billion in 2014 from $ 6.5billion in 2012. Developments and approvals for novel cord blood stem cells therapies is expected to drive the market growth. The market is expected to reach revenue of $56.4 billion by 2020, growing at CAGR of 33.4%during 2013 to 2020. The storage service market was valued at $7.4billion in 2013.

Get full access of the report at http://www.alliedmarketresearch.com/stem-cell-umbilical-cord-blood-UCB-market.

"Cord blood stem cell application is increasing at faster rate than other stem cell techniques because of its efficient and cost effective treatment process. Cord blood is assisting the healthcare industry to discover novel therapies on chronic diseases. UCB stem cell market is evidencing significant growth due to increasing public awareness and government support," state Allied Market Research analyst Debbie Shields and Roshan Deshmukh.

Browse all Diagnostics & Biotech market reports at http://www.alliedmarketresearch.com/diagnostic-and-biotech-market-report.

Increase in prevalence rate of chronic diseases such as cancer, diabetes, blood disease, immune disease, metabolic disease etc. has increased the need of cost effective and efficient way of treatment. However, cord blood stem cells have the potential to treat these chronic diseases effectively. These stem cells have special property of higher cell count in lower blood volume. Collection of these stem cells is much easier than other stem cells and could be stored in specialized preservation facilities called as Cord Blood Stem Cell Banks.

Cord blood stem cells market is in its emerging phase. Significant applications of stem cells in the treatment of various disorders will be commercialized very soon as most of them are in the last phase of clinical trials. Patents for collection techniques and therapeutics methods are approved by respective government of developed countries however patents for UCB stem cells are comparatively less in developing economies.

Similar Market Studies by Allied Market Research

Biomaterials are artificially derived natural materials that are used in medical applications such as organ transplantation and replacement of tissues. The global market for medical devices was accounted to $240 billion in 2013. This shows the potential for growth of biomaterial market. Increase in aging population is the major driver for biomaterial market. Due to the increase in number of aging patients, the usage of biomaterial in wound healing, plastic surgery, neurology and tissue engineering is increasing. According to the Society for Biomaterials, there are more than 5000 novel research article published every year for improved wound care techniques and surgical devices. Biomaterials market growth is hindered by certain factors such as inflammatory responses and strict government regulations for commercialization. In 1999, Government of Norway conducted “Dental Biomaterial- Adverse Reaction Unit” activity to control and evaluate adverse implication in dental fields.

To see more, visit at http://www.alliedmarketresearch.com/biomaterials-market.

The bioinformatics market is expected to grow to $12.86 billion by 2020 with a CAGR of 21.2% during 2014-2020. Bioinformatics is an interdisciplinary field that is used in the development and storage of data, thus helping in the analysis, organization and retrieval of the biological data. Bioinformatics has various applications and thus forms part of almost all the fields in biology. Bioinformatics form a part of agriculture, animal breeding, molecular medicine, preventive medicine, etc.

To see more visit at http://www.alliedmarketresearch.com/bioinformatics-market

Synthetic biology is a novel field that finds its origin at the intersection of biology and engineering. It involves designing and construction of biological systems or devices that can be applied in varied domains to get specified results. It’s a multidisciplinary effort made by scientists to understand the functioning of biological organisms, cells & genes and implementation of artificial genetic processes to give specific characteristics to an organism. It can even be used to develop a completely new biological system. Global synthetic biology market was valued at $3.0 billion in 2013 and it is estimated to reach $38.7 billion by 2020, growing at a CAGR of 44.2% during the forecast period.

To see more, visit at http://www.alliedmarketresearch.com/synthetic-biology-market.

According to lead analyst Debbie Shields, the geographicanalysis shows that the North American market for cord blood stem cell would account for approx. 44% of total revenue generated by the cord blood market in 2013. However, much expected growth is to occur in Asia-Pacific regions during the forecast period, because of growing demand for chronic disease treatments and widely increasing awareness levels. This report study offers updated review about major market players present in this market such as researcher based pharmaceutical companies and therapeutics services companies.Company profiles in this report include - Advanced Cell Technology Inc., California Stem Cell Inc., Cytori Therapeutics Inc., Mesoblast Limited, Opexa Therapeutics Inc.(USA), Athersys Inc., Geron Corporation, and Neostem Inc.

About Us:

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based inPortland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
SonaPadman
5320 SW Macadam Avenue,
Suite 100, Portland, OR 97239
United States
Direct:    +1-(617)-674-4143
Toll Free: +1-(855)-711-1555 (U.S. & Canada)
Fax: +1-(855)-550-5975
Email: sales(at)alliedmarketresearch(dot)com
Web: http://www.alliedmarketresearch.com
Blog: http://blog.alliedmarketresearch.com/
Linkedin: http://www.linkedin.com/company/allied-market-research